Inositol (25-50 mg per mL): a carbocyclic sugar alcohol classified as part of the B-vitamin complex
Specific metabolic changes observed during GLP-1 treatment include: Improved insulin sensitivity , allowing cells to use glucose more efficiently Reduced hepatic glucose production , contributing to better glycaemic control Changes in body composition , with loss of both fat mass and some lean tissue Alterations in lipid metabolism , often resulting in improved cholesterol profiles Body composition studies suggest that lean tissue loss typically accounts for approximately 20-30% of total weight lost during GLP-1 therapy, though this varies considerably between individuals and depends on concurrent physical activity and protein intake
Potential Research Benefits Research suggests that modulation of the GH/IGF-1 axis may have implications for studies in muscle physiology, metabolic regulation, and tissue repair
Gently massage into the face and neck until absorbed
The tirzepatide before and after results and comparable retatrutide data suggest that the glucagon receptor component produces additional fat loss beyond what dual agonist therapy achieves, particularly for visceral fat
By way of background: I was diagnosed in 2014 after optic neuritis and some sensory loss
